Chemotherapeutic management of the hormone-secreting endocrine malignancies

Use of amifostine in bone marrow purging.

Seminars in oncology·1996

Organic thiophosphate WR-151327 suppresses expression of HIV in chronically infected cells.

AIDS research and human retroviruses·1994

Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy.

Cancer·1993

The role of hexamethylmelamine in the management of ovarian cancer.

Cancer treatment reviews·1991

New protective agents for bone marrow in cancer therapy.

Cancer investigation·1991

New sugar mitomycin C analogues: preparation, murine P388 antitumor activity, and leukopenia induction.

Journal of pharmaceutical sciences·1990

Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025.

Cancer·2026

Progression-free survival and overall survival in the first-line treatment of BRCA wild-type advanced epithelial ovarian cancer: An analysis of patient-level data pooled from historical clinical trials.

Cancer·2026

Trends in sociodemographic factors associated with human papillomavirus vaccine hesitancy in the United States: 2010-2022.

Cancer·2026

External validation of the NADIR model for early prostate-specific antigen response prediction in enzalutamide-treated metastatic hormone-sensitive prostate cancer: An analysis of the ARCHES trial.

Cancer·2026

Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.

Cancer·2026

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis.

Cancer·2026

Biological effects of N-acetylcysteine, calcium hydroxide, chlorhexidine and their combinations as intracanal medications: cytotoxicity, genotoxicity and cytokine modulation.

BDJ open·2026

Clinical Determinants Influencing First-line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma in Japan.

Anticancer research·2026

Comparing the real-world effectiveness of oral corticosteroids and antifungals for the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

Chest·2026

Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice.

PLoS neglected tropical diseases·2026

Bifunctional Nanozymes for Synergistic Treatment by Boosting Oxidative Stress and Regulating the Protein Kinase B Pathway.

ACS nano·2026

SRPK Inhibition in Cholangiocarcinoma Cells Induces LAMB1-Associated Adaptive Responses and Enhances Growth Suppression by the MEK Inhibitor U0126 via the LAMB1/ERK/c-JUN Axis.

Frontiers in bioscience (Landmark edition)·2026

Related Experiment Videos

Chemotherapeutic management of the hormone-secreting endocrine malignancies

Related Concept Videos

Use of amifostine in bone marrow purging.

Organic thiophosphate WR-151327 suppresses expression of HIV in chronically infected cells.

Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy.

The role of hexamethylmelamine in the management of ovarian cancer.

New protective agents for bone marrow in cancer therapy.

New sugar mitomycin C analogues: preparation, murine P388 antitumor activity, and leukopenia induction.

Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025.

Progression-free survival and overall survival in the first-line treatment of BRCA wild-type advanced epithelial ovarian cancer: An analysis of patient-level data pooled from historical clinical trials.

Trends in sociodemographic factors associated with human papillomavirus vaccine hesitancy in the United States: 2010-2022.

External validation of the NADIR model for early prostate-specific antigen response prediction in enzalutamide-treated metastatic hormone-sensitive prostate cancer: An analysis of the ARCHES trial.

Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis.

Biological effects of N-acetylcysteine, calcium hydroxide, chlorhexidine and their combinations as intracanal medications: cytotoxicity, genotoxicity and cytokine modulation.

Clinical Determinants Influencing First-line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma in Japan.

Comparing the real-world effectiveness of oral corticosteroids and antifungals for the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice.

Bifunctional Nanozymes for Synergistic Treatment by Boosting Oxidative Stress and Regulating the Protein Kinase B Pathway.

SRPK Inhibition in Cholangiocarcinoma Cells Induces LAMB1-Associated Adaptive Responses and Enhances Growth Suppression by the MEK Inhibitor U0126 via the LAMB1/ERK/c-JUN Axis.

Related Experiment Videos

Chemotherapeutic management of the hormone-secreting endocrine malignancies

Related Concept Videos

Related Articles